Replies to post #2168 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

>That's a twist that surprises me. No talk about enabling the production of difficult-to-express proteins with GlycoFi's technology?<

None on yesterday’s MRK webcast. If you subscribe to Science, you can read the paper they published (#msg-13169472) and let us know what you think :-)